BioSpace News Archive

SOC Telemed (SOC), the leader in acute care telemedicine, will participate in the 2018 Race for Every Child as a Results Sponsor, benefitting Children’s National Health System.

A new study in JAMA Network Open underscores the risk to patients if the Anthem Blue Cross Blue Shield policy to deny emergency coverage based largely on a patient’s diagnoses after a visit, is adopted nationwide.

BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2019

Beachwood-based Bahman Guyuron, M.D., authored a new textbook, “Migraine Surgery” published by Theime, an international medical and science publisher

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the U.S. Food and Drug Administration has approved Dupixent® (dupilumab

LumiThera® Inc., a commercial-stage medical device company focused on developing photobiomodulation (PBM) therapies for ocular disorders and disease, today announced that it will present at the Ophthalmology Innovation Summit at the American Academy of Ophthalmology (OIS@AAO) meeting on October 25, 2018, in Chicago, IL.

U.S. Sen. Martin Heinrich is among the dignitaries expected to attend the International Water, Sanitation and Hygiene (IWSH) Foundation’s 2018 Community Plumbing Challenge, which begins Monday in Thoreau, New Mexico.

As an advocate for the genomics age, Integrated DNA Technologies (IDT), will showcase its renowned CRISPR expertise at a series of European-focused events.

QED Therapeutics today announced the presentation of positive, updated interim data of infigratinib (BGJ398), an orally administered, selective fibroblast growth factor receptor (FGFR) 1-3 tyrosine kinase inhibitor

The Company brings together supported dentists for a weekend of education and celebration